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Arginase is a major pathway of L-arginine metabolism in nephritic
glomeruli. L-arginine can be metabolized to nitric oxide (NO) by nitric
oxide synthase (NOS) and to urea and L-ornithine by arginase. Com-
petition between these pathways for L-arginine in inflammatory sites
has been suggested. In experimental glomerulonephritis glomeruli pro-
duce nitrite; a major source is macrophages. We hypothesized that
arginase is present in glomeruli and may compete for substrate with
NOS in glomerulonephritis. Therefore we examined both pathways in
isolated nephritic glomeruli and peritoneal macrophages. Arginase
activity was present in glomeruli, increased by >500% in nephritic
glomeruli compared to controls, and was predominant over NOS.
Activity increased with L-NMMA (a NOS inhibitor), but this trend did
not reach statistical significance. In macrophages both pathways were
present; NOS predominated basally but this was reversed by
L.NMMA. In contrast with glomeruli macrophage arginase activity
increased after LPS stimulation. Levels of macrophage arginase activ-
ity could not account for activity in nephritic glomeruli, suggesting
another source of arginase. This is the first demonstration of high
arginase activity of nephritic glomeruli. Competition between arginase
and NOS pathways suggests a regulatory mechanism of L-arginine
metabolism within the glomerulus, with implications for the pathogen-
esis of injury and scarring in glomerulonephritis.
fluids are low. Currie, Gyure and Cifuentes [81 suggested that
arginase activity may compete for L-arginine in the microenvi-
ronment of an inflammatory site. Hibbs et a! [9, 10] have
attributed the cytotoxic effects of activated macrophages to
nitric oxide. Arginase however has been reported to inhibit
tumor cell growth [11], and a strong relation between increased
arginase activity and allograft rejection has been reported [12].
We studied both pathways of L-arginine metabolism in iso-
lated glomeruli in nephrotoxic nephritis under basal conditions
and with exogenous stimuli known to activate or inhibit induc-
ible NOS. We also studied these events in isolated macro-
phages, as these cells form a major component of the inflam-
matory reaction in nephrotoxic nephritis.
Methods
Animals
Inbred male Lewis rats (St. Mary's Hospital Medical School)
were used for all experiments.
Induction of glo,nerulonephritis
L-arginine is the substrate for nitric oxide synthesis in
mammalian cells and is also metabolized to L-ornithine and
urea by the action of arginase. We have recently reported that
glomeruli in experimental glomerulonephritis synthesize nitrite
(NO2—) from L-arginine via nitric oxide [1, 2], and have
produced evidence that the major source is macrophages infil-
trating the glomerulus [3]. Activated macrophages accumulate
and are responsible for glomerular injury in the nephrotoxic
model, but the mechanisms of injury are still unknown.
As macrophages can express both NOS and arginase activi-
ties 14—61, we investigated the hypothesis that the arginase
pathway is also present in the glomerulus and may compete for
substrate with NOS in glomerulonephritis.
Recently Albina et al [7] have examined the temporal expres-
sion of different pathways of L-arginine metabolism in healing
wounds in the rat, and showed that early in the course of wound
healing levels of nitric oxide synthase are high, whereas later
there is high arginase activity and arginine levels in wound
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Accelerated nephrotoxic nephritis was induced as previously
described [1]. Both nephritic and rabbit globulin (RG) immu-
nized control rats were fed a nitrite and nitrate free diet from
three days before preimmunization until the end of the experi-
ment as part of a study of urinary nitrate excretion to be
reported elsewhere. Rats were immunized with I mg rabbit
immunoglobulin (Sigma) in Freunds complete adjuvant (Sigma)
i.p. seven days before an i.v. subnephritogenic dose of rabbit
anti-rat nephrotoxic globulin (nephritic rats) or control rabbit
globulin (RG immunized control rats). Urine was collected from
rats placed in metabolic cages. Proteinuria was measured by
sulphosalicylic acid method.
Glomerular isolation
Glomeruli were isolated from control or nephritic kidneys
perfused in vivo with 50 ml sterile pyogen free saline (Phoenix
Pharmaceuticals, Gloucester, UK) at room temperature as
previously described [13] three days after i.v. globulin. They
were washed twice and plated at 2000/mI in 16mm plastic tissue
culture wells (Nunc, Uxbridge, UK) and incubated for 48 hours
at 37°C under 4% CO2. Culture medium was DMEM without
phenol red supplemented with 10% FCS (Flow laboratories);
glutamine (Sigma) 584 mg/liter; and penicillin 100 U/mI, strep-
tomycin 100 p.g/ml and amphotericin B 250 ng/ml (Sigma). The
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concentration of L-arginine in this medium is 0.4 m. The FCS
contained 0.12 ng/ml endotoxin as determined by the supplier.
L-[Guanido- '4C]-arginine (NEN, Cambridge, Massachusetts,
USA) (0.25 /LM) was added to medium to provide approximately
2 x i05 cpm/ml. Medium in some wells was supplemented with
LPS (E. coli 0127:B8, Sigma) I JLg/ml or 100 tg/ml, or with 300
M NGmonomethy1Larginine (L-NMMA, gift of Dr. S. Mon-
cada, Wellcome Research Laboratories, Beckenham, Kent,
UK).
Iso/a non of peritoneal macrophages
Peritoneal macrophages were obtained by peritoneal lavage
with calcium free perfusion buffer (pH 7.4) from rats injected
six days previously i.p. with 10 ml thioglycollate broth (Oxoid)
or rats injected 10 days previously with 0.2 ml Corynebacterium
parvum (7 mg/mI) (Wellcome). Macrophages were plated at
106/ml in 16 mm wells and after two hours of incubation were
washed three times to remove non-adherent cells. They were
cultured in DMEM without phenol red supplemented with 10%
FCS, glutamine 584 mg/liter, and penicillin 100 U/mI, strepto-
mycin 100 g/ml and amphotericin B 250 ng/ml (normal me-
dium) for 48 hours at 37°C under 4% CO2. Medium in some
wells was supplemented with L-[Guanido-'4C]-arginine to pro-
vide approximately 2 x l0 cpm/ml for extracellular arginase
activity assay. In experiment 1 thioglycollate macrophages
were studied for N02, intra- and extracellular arginase activ-
ity. Medium in some wells were supplemented with rat gamma-
interferon 100 U/mI (IFN, Holland Biotechnology By, Leiden,
The Netherlands) or with LPS I g/m1 or 100 g/ml, or with 300
sM L-NMMA. In experiment 2 thioglycollate and C. parvum
macrophages were studied. In some of these experiments
L-arginine free DMEM with FCS and antibiotics as above was
used to determine the effects of low L-arginine concentrations
on N02 production and viability.
Nitrite assay
Nitrite (NO2—) in culture supernatants was measured at 48
hours by the Griess reaction as previously described [141.
Briefly, 100 p1 sample and 100 sl Griess reagent were added to
a multiplate well and absorbance was read at 550 nm.
Arginase activity
Generation of 14C-urea from '4C-arginine in culture superna-
tants (extraceltular arginase activity) was determined by the
method of Russell and Ruegg [15]. After48 hours of culture 150
p1 of supernatant was removed and added to 0.8 ml of pH 4.5
buffer containing 250 m acetic acid, 100 m urea and 10 mrt
L-arginine (Sigma). Three hundred microliters of a continu-
ously stirred suspension of Dowex resin (SOW x 8,100 to 200
mesh H form, I g/ml) was then added. The tubes were shaken
for one minute and then centrifuged at 750 rpm (120G) for five
minutes. Five hundred microliters of supernatant containing
'4C-urea was added to 3 ml Ecoscint scintillation fluid and the
radioactivity was counted. Percentage conversion of '4C-argi-
nine to '4C-urea was calculated as follows: [(cpm in 500 p1
supernatant — cpm in medium without cells) / 0.36 x (cpm in
150 p1 unseparated medium)] x 100.
Intracellular arginase activity of 106 thioglycollate macro-
phages was measured after 48 hours incubation. Medium was
removed from each well and cells were lysed with 0.3 ml 0.01%
Triton X-100 pH 7.5 containing bovine serum albumin (2
mg/ml), 10 mri MnCl, and 12 mtvi Na-maleate. Briefly, to 50 p1
samples 150 p1 of 100 msi glycine buffer pH 9.7 was added,
samples and substrate were prewarmed and incubated in a
waterbath at 37°C. Substrate of 50 p1 250 mM L-arginine
containing L-[Guanido- '4C]-arginine (approximately l0 cpm/50
ml) was added. After exactly 20 minutes the reaction was
stopped by adding 0.8 ml of pH 4.5 buffer containing 250 m
acetic acid, 100 m urea and 10 mM L-arginine. '4C-urea was
separated using Dowex and counted on a scintillation counter
as above. Units of intracellular arginase activity were calcu-
lated as follows: U/b6 cells = tmol urea produced/mm/b6
cells at 37°C and pH 9.7 = 625 x [(cpm in 500 p1 separated
sample — cpm in separated medium without cells)/20 X cpm in
50 p1 L-arginine substrate '4C-arginine)].
Viability assay
Viability of isolated macrophages in culture after 48 hours
was determined using a modified method described by Jones
and Senft [16] using Fluorescein Diacetate (FDA, Sigma) I
mg/mI in acetone and ethidium bromide (El, Sigma) 5 mg/mI in
RPM! stock solutions. A 50 .d drop of 2 ml PBS containing 20
p1 of El and 30 p1 of FDA stock was placed on each well. The
preparations were examined using a fluorescent microscope.
With this method viable cells stain green while the nuclei of
non-viable cells stain red. Viability was expressed as percent-
age viable/total cell counted, (mean total cells counted >300).
Protein assay
Protein content per well was estimated using a micro-BCA kit
(Pierce; Rockford, Illinois, USA) after lysing macrophages with
I ml 0.01% Triton X-100 and repeated freezing and thawing.
Statistics
All data are presented as mean SEM. N02 production is
expressed as nmol N02, extracellular arginase activity is
expressed as % conversion of '4C-arginine to '4C-urea or as
nmol urea calculated from % conversion and the known L-argi-
nine concentration in the medium. Intracellular arginase activ-
ity is expressed as nmol urea produced per mm at pH 9.7 and
37°C. Data were analyzed for statistical significance by paired
or unpaired Student's t-test as appropriate with P <0.05 taken
as significant.
Results
Glomerulonephrinis: NOS and arginase activity in glomeruli
Three days after i.v. nephrotoxic globulin nephritic rats were
proteinuric (115 16 mg/24 hrs, N = 4). Histology showed a
mild proliferative glomerulonephritis.
Glomerular N02 production is shown in Table 1. The basal
NO2- production by nephritic glomeruli was higher than by
control glomeruli. When stimulated with either 1 or 100 g/ml
LPS the N02 production by nephritic glomeruli was signifi-
cantly higher than when unstimulated or when compared to
production by control glomeruli. LPS stimulated N02 produc-
tion in nephritic glomeruli was significantly inhibited by
L-NMMA.
The metabolism of L-arginine to urea (extracellular arginase
activity) by nephritic glomeruli is also shown in Table 1. For the
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Table 1. NO,- production and arginase activitya of isolated glomeruli, (N = 4) after 48 hours in culture
nmol N02/2000 glomeruli nmol urea/2000 glomeruli
L-NMMA Nephritic Control Nephritic Control
Basal — 7.4 1.8 3.3 0.2 84.3 16b 14.8 5.0
+ 4.8 0.9 3.7 0.6 99.3 33 16.8 2.3
LPS I g/m1 — 17.3 3•6b 3.2 1.0 63.6 11" 16.0 3.8
+ 5.0 0.9c 2.8 0.5 104.2 29 19.3 6.5
LPS 100 g/m! — 61.8 107b,d 4.8 0.5 65.3 12b 18.2 3.6
+ 9.5 2.2C 4.4 1.8 159.0 50 27.8 9.0
a Expressed as nmol ureaJ2000 glomeruli
l, P < 0.033 compared to control
P < 0.026 compared to incubation without L-NMMAd P < 0.012 compared to basal and LPS I pg/mI
first time we show that there is arginase activity in isolated
glomeruli. Nephritic glomeruli showed a significant 5.7-fold
increase (P = 0.015) in basal arginase activity (84.3 16 nmol
ureaJ2000 glom) compared with control glomeruli (14.8 5
nmol ureaJ2000 glom).
When stimulated with I or 100 ig/ml LPS, arginase activity in
nephritic glomeruli tended to decrease but was still significantly
higher than in control glomeruli (P  0.022). This effect of LPS
was not observed in the control glomeruli. Addition of
L-NMMA induced a 1.2- to 1.8-fold increase in arginase activity
in nephritic glomeruli stimulated with I or 100 sg/ml LPS (104.2
29 and 159 50 nmol ureaJ2000 glom), although these
changes did not reach statistical significance. In the control
glomeruli addition of L-NMMA also induced a small, not
significant increase in arginase activity. In controls, arginase
activity never rose above 27.8 9 nmol urea/2000 glom.
Calculated ratio's of arginase activity compared to N02
production (A/N ratio) for each individual rat showed a pre-
dominance of the arginase pathway in nephritic and control
glomeruli, both basally and stimulated. The A/N ratio was 4.8 to
1 in control glomeruli and in nephritic glomeruli this ratio was
14.2 to 1, almost threefold higher. After LPS stimulation the
A/N ratio in nephritic glomeruli fell to 1.1 to 1 and in controls to
3.8 to I. Addition of L-NMMA increased the A/N ratio in
nephritic glomeruli both basally and when stimulated with LPS.
Peritoneal macrophages
Experiment 1: NOS and arginase activity in thioglycollate
macrophages.N02 production of thioglycollate (TG) macro-
phages after 48 hours in culture is shown in Figure 1. Stimula-
tion with gamma-interferon (IFN) induced a significant increase
in N02 production, which could be significantly inhibited with
L-NMMA. Highest N02 production was seen after stimula-
tion with 1 or 100 tg/ml LPS, also significantly inhibited with
L-NMMA.
The metabolism of L-arginine to urea by peritoneal macro-
phages in culture (extracellular arginase activity) is shown in
Figure 2. Basal extracellular arginase activity was present (7.8
0.3 nmol ureaJlO6 macrophages). Activity increased slightly
after stimulation with IFN (10.9 0.8) or LPS (12.8 1.2 and
12.5 0.6 nmol ureaJlO6) but this increase did not reach
statistical significance. However, when L-NMMA was added,
basal and IFN or LPS stimulated macrophages showed a
fourfold, significant increase (P 0.002) in arginase activity.
Ratios of extracellular arginase activity compared to N02
production (A/N ratio) of macrophages showed a predominance
of the NOS pathway, which reversed to arginase predominance
after addition of L-NMMA. The basal A/N ratio was 0.28 to 1
and fell to 0.20 to 1, and 0.16 and 0.15 to 1 after stimulation with
IFN, LPS I or 100 g/ml, respectively. Addition of L-NMMA
increased the A/N ratio both basally and when stimulated with
either IFN or LPS to around 3 to 1.
Figure 3 shows the intracellular arginase activity of TG
macrophages lysed after 48 hours in culture with or without
IFN or LPS. The basal intracellular arginase activity was 19.3
nmol urealmin/106 macrophages. Activity significantly in-
creased (P 0.002) after stimulation with LPS (71.3 4.7) or
IFN (39 2.2 nmol urea/min/106 macrophages).
Experiment 2: Comparison of N02, arginase and viability in
thioglycollate and C. parvum macrophages. Effects of low
L-arginine concentrations on N02 production. We compared
thioglycollate (TG) elicited and C. parvum activated macro-
phages and investigated the effects of arginine depletion on
NOS through incubation in L-arginine free (LAF) medium.
Table 2 compares L-arginine metabolism in TG and C.
parvum macrophages, and therefore compares the difference










Fig. 1. Nitrite production by thioglycollate ,nacrophages after 48
hours in culture. Hatched columns represent incubations with 300 M
L-NMMA, N = 6 except LPS 100 (N = 3). p < 0.014 compared to
incubations without LNMMA; **D < 0.00 I compared to basal; *** <
0.001 compared to IFN.
Basal IFN LPS 1 LPS 100
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Basal IFN LPS 1 LPS 100
Fig. 2. Extracellular arginase activity of thiog!vcollate macrophages
after 48 hours in culture, calculated from con version of '4C-arginine to
urea. Hatched columns represent incubations with 300 LM
L-NMMA; N = 6, except LPS 100 (N = 3). p 0.002 compared to
incubations without LNMMA.
production was significantly higher in C. parvum than TO
macrophages, and was significantly inhibited with L-NMMA in
both. Gamma-IFN stimulation increased N02 production in
TG macrophages, but not in C. parvum macrophages. Extra-
cellular arginase activity in contrast was lower in C. parvum
macrophages. As before, after addition of L-NMMA the argi-
nase activity increased significantly both in basal and stimulated
TG and C. parvum macrophages.
In the additional experiments where LAF medium was used
basal and stimulated N02 production by macrophages was
significantly reduced: basal 15.1 1.5 (TO), 50.7 0.6 (C.
parvum), P 0.02; gamma-IFN 21.4 1.5 (TO), 40.3 0.2 (C.
parvum), P  0.02 compared with results in normal medium.
In both TG and C. parvum macrophages the basal viability of
92 and 85% fell after stimulation with IFN to 75 and 73%
respectively, an effect which was abolished by addition of
L-NMMA or incubation in LAF medium.
Figure 4 shows the intracellular arginase activity of C.
parvum macrophages lysed directly after harvest and adherance
or after 48 hours in culture with or without IFN. Intracellular
activity directly after harvest and adherance was very low, 0.72
0.2 nmol urealmin/l06 macrophages. Basal intracellular argi-
nase activity after 48 hours was 6.5 0.7 nmol urealmin/106
macrophages. Unlike in TO macrophages (Fig. 3), this activity
could not be significantly stimulated with IFN. The intracellular
arginase activity in lysed C. parvum macrophages was half that
of lysed TO macrophages.
Discussion
In this study we show activity of both NO synthase and
arginase pathways of L-arginine metabolism in glomeruli. We
have previously demonstrated that nephritic glomeruli metabo-
lise arginine to nitric oxide [1, 21, and have shown that infiltrat-
ing macrophages are the major source [3]. Arginine may also be
metabolized to urea and ornithine, and this reaction is catalyzed
by arginase.
Fig. 3. Intracellular arginase activity of thioglycollate macrophages
after 48 hours in culture, N = 3* 0.002 compared to basal; ** =
0.008 compared to IFN.
In the present study we demonstrate that glomeruli in culture
possess arginase activity, that this activity is at least six times
higher in nephritic glomeruli compared with controls. It appears
to account for most of the arginine metabolism under basal
conditions. In RG immunized control glomeruli, although the
absolute values are lower than in nephritic glomeruli, the
arginase pathway is also the main pathway of arginine metab-
olism.
It is important to consider the source of this arginase activity
in both nephritic and control glomeruli. Arginase activity has
been found in various cell types including fibroblasts [17, 18],
and macrophages [5—8, 11, 12, 15, 19, 201, and Albina et al [7]
have suggested that in wounds macrophages are likely to be the
major source of arginase. In the glomerulus the possible sources
are macrophages or intrinsic glomerular cells. We therefore
studied the levels of arginase activity in both elicited and
activated types of peritoneal macrophages under various con-
ditions.
The results we found for macrophage arginase activity are
comparable with those in other studies [8, 11, 20]. The maximal
arginase activity (without L-NMMA) we found was in thio-
glycollate elicited macrophages stimulated with LPS; these
cells produced 12.8 nmol ureallO6 cells/48 hours. This compares
with production by nephritic glomeruli of 84.3 nmol/2000
gloms/48 hours. We have found previously that macrophage
infiltration in this model amounts to a maximum of 200 macro-
phages/glomerulus and thus 2000 glomeruli might maximally
contain 0.4 x 106 macrophages. From these figures infiltrating
macrophages are unlikely to be the source of the glomerular
arginase activity we have measured. Further supporting this,
macrophages infiltrating glomeruli in immune complex glomer-
ulonephritis are of activated type, resembling C. parvum cells
rather than thioglycollate elicited macrophages [21, 221. In our
experiments C. parvum cells showed less arginase activity than
those elicited by thioglycollate. In addition, in unstimulated
































P < 0.045 compared to incubation without L-NMMAb P < 0.022 compared to basal












Fig. 4. Intracellular arginase activity of C. parvum ,nacrophages,
direct/v lysed after harvest and incubation (DL) or after 48 hours in
culture (basal, IFN) N = 3.
whereas in thioglycollate macrophages the ratio of urea/nitrite
production was 0.28 and in C. parvum macrophages even
lower, 0.07. We therefore suggest that much of the arginase
activity may originate from intrinsic glomerular cells rather than
macrophages, although a definite answer will require isolation
of cell populations from nephntic glomeruli.
It has been suggested that NO produced by macrophages in
culture induces cell death. We have shown that in macrophages
there is a loss of viability after IFN stimulation, an effect which
is abolished by the NOS inhibitor L-NMMA and reduced in
L-arginine free medium. These results also suggest, as has been
previously reported [23], that intracellular sources of L-arginine
exist.
The relation between intra- and extracellular arginase activity
has not yet been fully established. We showed higher intracel-
lular arginase activities in TG macrophages than C. parvum
macrophages which corresponded with their extracellular argi-
nase activity. Intracellular activity could be stimulated by IFN
or LPS in TG macrophages, which was not reflected in the
extracellular activity possibly because of the fact that the
increased activity of NOS competes for substrate.
The presence of the arginase pathway within glomeruli raises
the possibility that macrophages and intrinsic glomerular cells
may compete for arginine and that increased glomerular argi-
nase activity in glomerulonephritis might limit the arginine
available for NO production. If this were so, then an increase in
urea generation should occur if the NOS pathway is inhibited.
Indeed, we did find increased urea from nephritic glomeruli
treated with L-NMMA, but this did not reach statistical signif-
icance. We found a decrease in urea production by nephritic
glomeruli when NOS was stimulated with LPS, which also
suggests competition. The activity of each pathway may vary
with time as has been shown for wounds [71, and therefore
sequential studies will be of interest.
Apart from possible competition for arginine, arginase in
glomeruli may also play a role in mesangial proliferation and
glomerular scarring. Arginine metabolism via arginase produces
L-ornithine which is a precursor for proline, which can be
incorporated into collagen, and also for polyamines. An in-
crease in generation of polyamines has been shown to be
associated with proliferation and repair in various cell types.
Recently Schulze-Lohoff et al [241 have shown that ornithine
decaboxylation to polyamines is associated with mesangial cell
proliferation.
In conclusion, we have demonstrated that glomeruli in vitro
are able to metabolize arginine via the arginase pathway as well
as via the nitric oxide synthase pathway. Arginase activity is
present at a low level in control glomeruli predominant over
nitrite production through NOS, and is markedly increased in
nephritic glomeruli. The data from peritoneal macrophages
suggest that infiltrating macrophages are unlikely to be the
major source of arginase in nephritic glomeruli. The presence of
both pathways of arginine metabolism in glomeruli implies
possible competition for available substrate, and a balance
between the haemodynamic and cytotoxic effects of NO and the
stimulatory effect of products of the arginase pathway on cell
proliferation and matrix production. Glomerular arginase activ-
ity may therefore have major implications for glomerular patho-
physiology
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